Protons 101

Head and Neck Cancer: Approach and Modality are creating variance.

Progress can be a double edged sword. An example of a 70% reduction in dose.

Sep 7 • 

Mark Storey MD

1

August 2025

New Radiation Cancer Facility Opens. Radiation Oncology throws stones.

What's worse than the Death Star of medicine? A carbon ion Death Star. At least if you listen to our own field.

Aug 17 • 

Mark Storey MD

8

10

July 2025

Technology or Margins?

Where do you land? A thought piece on what might lie ahead for our field.

Jul 13 • 

Mark Storey MD

4

3

June 2025

Head and Neck Cancer: Overall Survival Benefit with Protons...?

Updates from PTCOG in Argentina. An initial look at the randomized prospective data.

Jun 22 • 

Mark Storey MD

4

PSA Screening: Data Speaks Loudly

Recommendations changed in 2012 and outcomes immediately worsened. What the data shows and how we can do better.

Jun 8 • 

Mark Storey MD

6

9

May 2025

IMRT De-escalation vs: Protons

How should we consider these two approaches?

May 18 • 

Mark Storey MD

5

2

Head and Neck Cancer: Elective Nodal De-Escalation

A New Era in elective nodal dosing is replacing a 60+ year standard.

May 4 • 

Mark Storey MD

11

2

May 2024

Protons vs. Photons: Esophageal Cancer

In Part 2 of this series, we'll look at the data for esophageal cancer

May 12, 2024 • 

Mark Storey MD

1

Protons vs. Photons: Lung Cancer

A look at data for where toxicities might differ between the two modalities

May 5, 2024 • 

Mark Storey MD

2

2

April 2024

Translating Non-Uniform RBE Modeling to the Clinic

A Concept... this time explained in more depth.

Apr 3, 2024 • 

Mark Storey MD

1

3

March 2024

Translating New RBE Modeling to the Clinic

A Concept...

Mar 24, 2024 • 

Mark Storey MD

5

IMRT is the de facto standard of care for the treatment of definitive disease

Prior authorization denials for IMRT in definitive cancer treatment cases should be an embarrassment to everyone in cancer care.

Mar 10, 2024 • 

Mark Storey MD

9